Last C$12.58 CAD
Change Today +0.17 / 1.37%
Volume 54.3K
As of 3:59 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

nordion inc (NDN) Snapshot

Open
C$12.47
Previous Close
C$12.41
Day High
C$12.58
Day Low
C$12.39
52 Week High
03/31/14 - C$12.84
52 Week Low
04/18/13 - C$6.89
Market Cap
778.8M
Average Volume 10 Days
241.3K
EPS TTM
C$1.66
Shares Outstanding
61.9M
EX-Date
09/10/12
P/E TM
6.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for NORDION INC (NDN)

Related News

No related news articles were found.

nordion inc (NDN) Related Businessweek News

No Related Businessweek News Found

nordion inc (NDN) Details

Nordion Inc., a health science company, provides various products and services for the prevention, diagnosis, and treatment of diseases worldwide. The company operates in two segments, Sterilization Technologies and Medical Isotopes. The Sterilization Technologies segment offers Cobalt-60, a radioactive metal that emits radiation and sterilizes items by destroying contaminating micro-organisms; and dosimetry and professional services, as well as designs, constructs, and maintains commercial gamma sterilization systems. The Medical Isotopes segment provides various products that are used in the diagnosis and treatment of diseases, including cardiac and neurological conditions, and various types of cancer. It offers Molybdenum-99, which decays into Technetium-99, a diagnostic that is used in nuclear medical procedures; Xenon-133 used in lung scans; Iodine-131 to treat hyperthyroidism, thyroid cancer, and non-Hodgkin’s lymphoma; Iodine-125 to treat prostate cancer; and Yttrium-90 to treat liver cancer and non-Hodgkin’s lymphoma. This segment also provides cyclotron isotopes, such as Iodine-123 to diagnose thyroid disease; Thallium-201 to diagnose and assess risk of coronary artery heart disease; Palladium-103 for treating prostate cancer; Strontium-82 for cardiac imaging; and Indium-111 and Gallium-67 to diagnose cancer, as well as offers radiopharmaceutical and contract manufacturing services. Nordion Inc. serves radiopharmaceutical and pharmaceutical manufacturers, biotechnology companies, manufacturers of medical supplies and devices, contract sterilizers, hospitals, and academic and government institutions, as well as to food and consumer goods industries. The company was formerly known as MDS Inc. and changed its name to Nordion Inc. in November 2010. Nordion Inc. was founded in 1946 and is headquartered in Ottawa, Canada.

400 Employees
Last Reported Date: 03/7/14
Founded in 1946

nordion inc (NDN) Top Compensated Officers

Chief Executive Officer, President, Non Indep...
Total Annual Compensation: $484.6K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $301.0K
Senior Vice-President of Corporate Services
Total Annual Compensation: $248.8K
Compensation as of Fiscal Year 2012.

nordion inc (NDN) Key Developments

Nordion Inc., Sterigenics International, Inc. - M&A Call

To enter into definitive agreement to be acquired by Sterigenics

Andrew Taylor Joins MDS as Non-Executive Director

MDS announced that Andrew Taylor has joined the MDS Board as a Non-Executive Director, to support the company's growth plans. He is currently Group CEO of Nomad Digital.

Nordion Continues With Reviewing Strategic Alternatives

Nordion Inc. (TSX:NDN) is planning to continue with its strategic alternatives review. Steve West, Chief Executive Officer of Nordion said, "We continue to maintain our focus on completing our strategic review." Nordion said, "During Q4 2013 and to date in fiscal 2014, Nordion continued to advance the second phase of the review. Completing the strategic review continues to be a priority for Nordion in fiscal 2014. Certain decisions, including the use of the Company's current cash, are expected to be made as part of or once the outcome of the strategic review has been finalized. While Nordion cannot provide the current status of, or address the timeline and potential results of the strategic review, the Company is working diligently with the objective of reaching a successful outcome."

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NDN:CN C$12.58 CAD +0.17

NDN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bioanalytical Systems Inc $2.81 USD +0.10
Eckert & Ziegler AG €24.38 EUR +0.375
Harvard Bioscience Inc $4.33 USD -0.15
Ion Beam Applications €9.52 EUR -0.28
Sirtex Medical Ltd A$15.46 AUD -0.24
View Industry Companies
 

Industry Analysis

NDN

Industry Average

Valuation NDN Industry Range
Price/Earnings 2.6x
Price/Sales 2.8x
Price/Book 1.5x
Price/Cash Flow 2.5x
TEV/Sales 1.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NORDION INC, please visit www.nordion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.